Current Oncology, Free Full-Text
Por um escritor misterioso
Last updated 07 junho 2024
Background: Information on immune responses in cancer patients following mRNA COVID-19 vaccines is still insufficient, but generally, patients had impaired serological responses, especially those with hematological malignancies. We evaluated serological response to COVID-19 mRNA vaccine in cancer patients receiving chemotherapy compared with healthy controls. Methods: In total, 195 cancer patients and 400 randomly selected controls who had been administered a Pfizer-BioNTech or Moderna COVID-19 vaccines in two doses were compared. The threshold of positivity was 4.33 BAU/mL. Patients were receiving anticancer treatment after the first and second dose of the vaccines. Results: a TOTAL OF 169 patients (87%) had solid tumors and 26 hemolymphopoietic diseases. Seropositivity rate was lower in patients than controls (91% vs. 96%), with an age/gender-adjusted rate ratio (RR) of 0.95 (95% CL = 0.89–1.02). Positivity was found in 97% of solid cancers and in 50% of hemolymphopoietic tumors. Both advanced and adjuvant therapy seemed to slightly reduce seropositivity rates in patients when compared to controls (RR = 0.97, 95% CL = 0.89–1.06; RR = 0.94, 95% CL = 0.87–1.01). Conclusions: the response to vaccination is similar in patients affected by solid tumors to controls. On the contrary, hemolymphopietic patients show a much lower response than controls.
The Complete Guide To Becoming An Oncology Doctor
Noninvasive detection of any-stage cancer using free glycosaminoglycans
Radiation Oncology Market Share Will Increase at 4.6% CAGR Globally by 2030
World Cancer Research Journal - Online Review
Prostate Cancer - INTRODUCTION - Uroweb
FDA Approvals in Oncology: April-June 2023 - American Association for Cancer Research (AACR)
Frontiers Molecular Diagnostics in Clinical Oncology
Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs - The Lancet Oncology
Artificial intelligence in oncology: current applications and future perspectives
Cancer treatment and survivorship statistics, 2022 - Miller - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition
Journal of Current Oncology: Sage Journals
Frontiers Cell-Free DNA: Hope and Potential Application in Cancer
Home Page: Clinical Oncology
Home Page: Journal of Thoracic Oncology
Recomendado para você
-
Manual de Rede Sudeste by CARE PLUS - Issuu07 junho 2024
-
In Memoriam: Remembering Gustav Meier – Peabody Magazine07 junho 2024
-
Nav: plataforma de exames, consultas médicas e vacinas Dasa07 junho 2024
-
IJMS, Free Full-Text07 junho 2024
-
LUCRO LÍQUIDO DA NEOENERGIA SOFRE QUEDA DE 92,2% NO SEGUNDO07 junho 2024
-
Unidade Carolina Méier > Laboratórios07 junho 2024
-
The Technique of Calculation - Chess Lessons07 junho 2024
-
Frontiers Outcome of giant pituitary tumors requiring surgery07 junho 2024
-
Bronstein Medicina Diagnóstica - Méier I (Megaunidade), R. Dias da Cruz, Rio de Janeiro - RJ07 junho 2024
-
Apartamento 2 quartos à venda - Méier, Rio de Janeiro - RJ07 junho 2024
você pode gostar
-
VCT LOCK//IN 2023: Agent Pick Rates, VALORANT Esports News07 junho 2024
-
Camila (@CamilaSccp10) / X07 junho 2024
-
Aoshi Tokimitsu, Blue Lock Wiki07 junho 2024
-
The Ultimate Crosstrainer for Surfing, Carver Super Slab collab with Todd Proctor07 junho 2024
-
The True Story Behind 'Lone Survivor07 junho 2024
-
Sonic Feio VOLTOU!! (Carregou o filme nas costas com menos de 207 junho 2024
-
Este seria o vencedor em uma luta entre Sasuke e Neji em Naruto clássico07 junho 2024
-
Crunchyroll.pt - Como assim eu preciso treinar para atingir os meus objetivos? 😭 ⠀⠀⠀⠀⠀⠀⠀⠀ ~✨ Anime: Hunter x Hunter07 junho 2024
-
Telephone - Nelsun Grams07 junho 2024
-
An analysis of Mono's design and his arc. : r/LittleNightmares07 junho 2024